Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Devonyu / iStock with Getty Images
Johnson & Johnson (NYSE:Jnj) The initial results of a group of Sunrise-1, the first patient’s preliminary results for Tar-200, 2B of the 1st Phasiac 2B, chemotherapy Gemcitabine’s Intravese-free release system was directed to certain forms of bladder cancer.
